Cipher Pharmaceuticals Inc. Sustainability Profile
Cipher Pharmaceuticals Inc., headquartered in Canada, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative prescription products. Founded in 2000, the company has achieved significant milestones, including the successful launch of several unique therapies that address unmet medical needs. With a focus on dermatology and pain management, Cipher's core products, such as its proprietary formulations, stand out for their efficacy and patient-centric design. The company has established a strong market position, recognised for its commitment to quality and innovation. Through strategic partnerships and a robust pipeline, Cipher Pharmaceuticals continues to enhance its portfolio, making a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Cipher Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cipher Pharmaceuticals Inc.'s score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Cipher Pharmaceuticals Inc.'s reported carbon emissions
Cipher Pharmaceuticals Inc., headquartered in Canada, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Cipher Pharmaceuticals may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the pharmaceutical industry increasingly prioritises climate action, it will be essential for Cipher Pharmaceuticals to consider developing and implementing strategies to measure and reduce its environmental impact in the future.
How Carbon Intensive is Cipher Pharmaceuticals Inc.'s Industry?
How Carbon Intensive is Cipher Pharmaceuticals Inc.'s Location?
Cipher Pharmaceuticals Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cipher Pharmaceuticals Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
